Senseonics prices $41m underwritten offering for Eversense CGM

Senseonics (NYSE:SENS) said today that it priced an underwritten offering of 29 million shares of common stock at $1.41 apiece to a group of institutional investors. Roche Finance agreed to purchase 21 million shares and New Enterprise Associates agreed to purchase 7 million shares in the offering, according to the Germantown, Md.-based company. Senseonics said it expects to bring in $41 million from the offering, which is slated to close on June 1st. Get the full story at our sister site, Drug Delivery Business News. The post Senseonics prices $41m underwritten offering for Eversense CGM appeared first on MassDevice.
Source: Mass Device - Category: Medical Devices Authors: Tags: Diabetes Drug-Device Combinations Funding Roundup Research & Development Wall Street Beat Source Type: news